Role of Helicobacter pylori and p53 in regulation of gastric epithelial cell cycle phase progression

Digestive Diseases and Sciences

Volumn 47, Issue 5, 2002, Pages 987-995

  Zhang, Zun Wu ^a   Patchetf, Stephen E ^a   Farthing, Michael J G ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Apoptosis; Cell cycle; Gastric epithelial cells; H. pylori; P53; Serum starvation

Indexed keywords

PROTEIN P53;

APOPTOSIS; ARTICLE; BACTERIAL STRAIN; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; STOMACH EPITHELIUM; STOMACH MUCOSA; STRAIN DIFFERENCE;

APOPTOSIS; CELL CYCLE; DNA FRAGMENTATION; EPITHELIAL CELLS; GASTRIC MUCOSA; HELICOBACTER PYLORI; HOMEOSTASIS; HUMANS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036234803     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015069519610     Document Type: Article

References (51)

1. Helicobacter pylori infection: An overview
2. The risk of stomach cancer in patients with gastric or duodenal ulcer disease
3. Molecular mechanisms of Helicobacter pylori-associated gastric carcinogenesis
4. Interleukin- 1 polymorphisms associated with increased risk of gastric cancer
5. How does Helicobacter pylori cause mucosal damage? The inflammatory response
6. Helicobacter pylori and the cell cycle
7. Helicobacter pylori
8. Ornithine decarboxylase activity is a marker of premalignancy in longstanding Helicobacter pylori infection
9. Gastric epithelial cell kinetics in the progression from normal mucosa to gastric carcinoma
10. Induction of gastric epithelial apoptosis by Helicobacter pylori
11. Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: Effect of antibiotics and antioxidants
12. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach
13. + strains and dissociation of gastric epithelial cell proliferation from apoptosis
14. Relationship of Helicobacter pylori CagA status to gastric cell proliferation and apoptosis
15. The prevalence of Helicobacter pylori in peptic-ulcer disease
16. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin
17. Regulation of gastric epithelial cell growth by Helicobacter pylori: Evidence for a major role of apoptosis
18. Apoptosis in gastric epithelial cells is induced by Helicobacter pylori and accompanied by increased expression of BAK
19. Effect of Helicobacter pylori on gastric epithelial cell migration and proliferation in vitro: Role of VacA and CagA
20. Partial characterization of a cell proliferation-inhibiting protein produced by Helicobacter pylori
21. Helicobacter pylori increases proliferation of gastric epithelial cells
22. Helicobacter pylori strain-specific genotypes and modulation of the gastric epithelial cell cycle
23. 1 to S transition in AGS gastric epithelial cells
24. Hormones, vitamins, and growth factors in cancer treatment and prevention. A critical appraisal
25. Host determinants of Helicobacter pylori infection and its clinical outcome
26. The relation between gastric vitamin C concentrations, mucosal histology, and CagA seropositivity in the human stomach
27. + status to gastric juice vitamin C levels
28. Role of local cytokines in increased gastric expression of the secretory component in Helicobacter pylori infection
29. Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis
30. Helicobacter species and in vivo models of gastrointestinal cancer
31. Cell surface trafficking of Fas: A rapid mechanism of p53-mediated apoptosis
32. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip 1
33. Helicobacter pylori-associated gastritis in mice is host and strain specific
34. A standardized mouse model of Helicobacter pylori infection: Introducing the Sydney strain
35. Analysis of DNA, general methods
36. A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry
37. Suppression of Helicobacter pylori protease activity towards growth factors by sulglycotide
38. Susceptibility of growth factors to degradation by Helicobacter pylori protease: Effect of ebrotidine and sucralfate
39. Aminoacid utilization by Helicobacter pylori
40. Evaluation of different solid media used for cultivation of Helicobacter (Campylobacter) pylori
41. Cell proliferation and apoptosis
42. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis
43. Chemokines in the gastric mucosa in Helicobacter pylori infection
44. Gastric mucosal hydrophobicity in duodenal ulceration: Role of Helicobacter pylori infection density and mucus lipids
45. Duodenal Helicobacter pylori infection differs in cagA genotype between asymptomatic subjects and patients with duodenal ulcers
46. Mechanisms of Helicobacter pylori infection: Bacterial factors
47. Effect of Helicobacter pylori virulence factors on the induction of apoptosis and cell cycle phase progression of gastric AGS cells
48. Social controls on cell survival and cell death
49. Blood flow and free radical oxidation of lipids in gastric and duodenal mucosa in complicated duodenal ulcers
50. p53, the cellular gatekeeper for growth and division
51. Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines